Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

AstraZeneca PLC Consolidating 350 California Jobs to the Bay Area

AstraZeneca, with worldwide headquarters in Cambridge, UK, announced that it is consolidating some of its California staffers at The Cove at Oyster Point in South San Francisco.

Read More »

ADHD drugs no help with homework

Giving stimulants to kids with attention deficit hyperactivity disorder (ADHD) may not help them complete homework or get better grades, a small study suggests.

Read More »

Americas becomes first region to eliminate measles: health agency

The Americas has become the first region in the world to be free of measles, following a 22-year vaccination drive against the disease which continues to infect tens of thousands of people globally, the Pan American Health Organization said.

Read More »

Amgen’s Kyprolis falls short in study

Amgen’s multiple myeloma drug did not fare better than Takeda’s older therapy Velcade in a study involving patients who had not yet been treated for the disease.

Read More »

Kite Pharma Claims Success for Phase II CAR-T Study, Stock Soars

Shares of Kite Pharma were up after the company’s CAR-T therapy KTE-C19 demonstrated a 39 percent response rate, including a complete response rate of one-third of patients with various forms of Non-Hodgkin’s Lymphoma after three months of treatment, the company announced.

Read More »

Bristol-Myers to test Opdivo with Nektar drug

Bristol-Myers Squibb will evaluate the use of its blockbuster immunotherapy Opdivo with an experimental drug from Nektar Therapeutics to treat multiple cancers.

Read More »

Shire Terminates a Couple of Biosimilar Deals Made by Baxalta

After a strategic review of its portfolio after its acquisition of Baxalta, Shire has terminated two biosimilar deals: one with Momenta Pharmaceuticals and the other with Coherus Biosciences.

Read More »

Sanofi gets $43 million U.S. funding to spur Zika vaccine development

Sanofi SA said the U.S. Department of Health and Human Services (HHS) approved $43.18 million in funding to accelerate the development of a Zika vaccine, as efforts to prevent the infection gather momentum.

Read More »

3 Facts Life Sciences Companies Need to Know About Medical Claims

There are 3 key facts life sciences companies need to know about real-time or near real-time medical claims data to support timely business decision-making.

Read More »

Mylan faces scrutiny over EpiPen profit data shown to Congress

Mylan NV faced questions about the profit on its EpiPen emergency allergy treatment, following a report that the company makes 60 percent more on the injector than it had told Congress.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom